CN102313801A - Metabolic labeling method of antibody and application of antibody in fluorescence detection - Google Patents

Metabolic labeling method of antibody and application of antibody in fluorescence detection Download PDF

Info

Publication number
CN102313801A
CN102313801A CN201110148435A CN201110148435A CN102313801A CN 102313801 A CN102313801 A CN 102313801A CN 201110148435 A CN201110148435 A CN 201110148435A CN 201110148435 A CN201110148435 A CN 201110148435A CN 102313801 A CN102313801 A CN 102313801A
Authority
CN
China
Prior art keywords
antibody
group
metabolic marker
nitrine
metabolic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201110148435A
Other languages
Chinese (zh)
Inventor
张奇
白钢
侯洁
白芳
高智慧
潘鹏炜
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nankai University
Original Assignee
Nankai University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nankai University filed Critical Nankai University
Priority to CN201110148435A priority Critical patent/CN102313801A/en
Publication of CN102313801A publication Critical patent/CN102313801A/en
Pending legal-status Critical Current

Links

Images

Abstract

The invention provides a metabolic labeling method of an antibody and an application of the antibody in fluorescence detection. The method comprises the following steps that: two key compounds containing an azide group and an alkynyl group are respectively synthesized; the compound containing the azide group is added to a cell culture medium, and the azide group is labeled on a sugar chain of IgG through a metabolic pathway of a cell; and a click chemical reaction is carried out on the product obtained in the former step and the compound containing a fluorescence group to realize fluorescence color developing. With the adoption of the method, staining analysis can be performed in the cell level, and the metabolic labeled antibody can be directly used for immune fluorescent staining analysis; moreover, the antibody labeled by using the method can be used with the other existing immune fluorescent technologies synchronously, and the results are not interfered with one another. Compared with the traditional method, the novel antibody labeling method is easy to operate and less in steps, richens the immune fluorescent antibody detecting measures, and has development potential and wide application prospects in the future immune research.

Description

A kind of metabolic marker method of antibody and the application in the fluoroscopic examination thereof
Technical field
The invention belongs to the immunological technique field, relate to the metabolic marker method of antibody and carry out the method for immuning fluorescent dyeing analysis through click chemistry.
Background technology
[0002] click chemistry is the splicing through junior unit, and rapid and reliable is accomplished the chemosynthesis of varied molecule.It stresses the combinatorial chemistry new method that synthesizes the basis with carbon-heteroatom bond (C-X-C) in particular, and reacts advantages of simplicity and high efficiency to obtain molecular diversity by this.Because the click chemistry product is nontoxic, and good stability, be widely used in the outer and body inner analysis of drug screening, drug development, polymerization and other biosome.
Biological coupling technology is a kind of technology of biomacromolecule being modified through micromolecular compound; Use widely, like fluorophore tagged such as protein, nucleic acid, modification, part chelating, labelled with radioisotope etc. in fields such as molecular biology and chemicobiologies.
The immunofluorescence antibody technique is to use special fluorescent marker covalently bound to any a kind of antigen or antibody, and the method that detects through fluorescent microscope.At present, fluorescent markers such as FITC, rhodamine have been widely used in the immunofluorescence analysis technology, in addition, utilize the immune detection system of biotin-avidin system, also are widely used.
 
Summary of the invention
The objective of the invention is to develop a kind of novel antibody labeling method; This method is compared with classic method possessed processing ease; Advantages such as step is few; To enrich immunology detection system and fluorescence antibody detection means, a kind of new antibody metabolic marker method and the application in fluoroscopic examination thereof are provided.
The present invention at first provides a kind of antibody metabolic marker method, and this method comprises:
Metabolic marker thing when synthesizing as glycoprotein with the non-natural monose that contains azido group; Its sugared structure can replace the normal monose in the NGP; Thereby make and be labeled protein and contain azido group; And then react through the click chemistry between azido group and the azide reaction group, make protein possess the label group that lighting function or coupling can be to be detected.
Described azide reaction group is to form the alkynyl compounds of triazole ring with azido group, and possesses the characteristic of fluorescing or contain the label group.
The described coupling group that possesses the characteristic of fluorescing comprises Cy3, Cy5, FITC, TRITC, PE, DAPI, Texas red, RB200, Indo-1 and quantum dot etc.
Described label group comprises His, GST, FLAG, HA and biotin etc.
 
The present invention provides a kind of application of antibody in fluorescence labeling and immunofluorescence analysis method of adopting metabolic marker method mark simultaneously.
 
The non-natural monose that the key compound that the present invention relates to promptly contains azido group comprises: non-natural monose 1,3,4,6-oxygen acetyl-2-'-deoxy-n-nitrine acetylmannosamine (1,3; 4,6-tetra-O-acetyl-N-azidoacetylmannosamine, Ac4ManNAz), 1,3,4; 6-oxygen acetyl-2-'-deoxy-n-nitrine acetyl sialic acid (1,3,4,6-tetra-O-acetyl-azido sialic acid; Ac4SiaNAz), 1,3,4,6-oxygen acetyl-2-'-deoxy-n-nitrine acetylgalactosamine (1; 3,4,6-tetra-O-acetyl-N-azidoacetylgalactosamine is Ac4GalNAz) with 1; 3,4,6-oxygen acetyl-2-'-deoxy-n-nitrine acetylglucosamine (1,3; 4,6-tetra-O-acetyl-N-azidoacetylglucosamine, Ac4GlcNAz) and detection compound 4-ethinyl-N-ethyl-1, the 8-naphthalimide.
Synthetic non-natural monose joined in the Hybridoma Cell Culture base cultivate; Make it to substitute natural monose, obtain the anti-her2 antibody of the Azide of metabolic marker, the azido group through alkynyl in the copper ion catalysis detection compound and metabolic marker antibody carries out the click chemistry reaction subsequently; Realize fluorescence developing; Its detectability can reach 0.1 μ g, and EC50 is 1 μ g, and carries out the fluorescent dye analysis verification at cellular level.
The present invention has synthesized non-natural monose compd A c4ManNAz, Ac4SiaNAz, Ac4GalNAz, Ac4GlcNAz and detection compound 4-ethinyl-N-ethyl-1 voluntarily; The 8-naphthalimide; Non-natural monose has and the ability that substitutes normal monose; And can specific click chemistry reaction take place with alkynyl, change 4-ethinyl-N-ethyl-1, the electron distributions of 8-naphthalimide.
Carry out metabolic marker with above-mentioned synthetic non-natural monose; Preparation contains azido group ground antibody; Set up the fluorescence antibody analytical approach of using this antibody, verified, confirmed the detection sensitivity and the detectability of this labeling method simultaneously through the immunofluorescence dyeing and the click chemistry method of cell.
 
The concrete steps of the nitrine labeling method of antibody provided by the invention are following:
The non-natural monose that will contain azido group slowly joins in the cell culture medium, and final concentration is 0.2 mM, join behind the mixing in the hybridoma, and 37 ℃, 5% CO 2Cultivate 72 h, the collecting cell suspension, centrifugal 3 min of 1000 r/min draw supernatant, with the antibody of antibody purification affinity column purifying metabolic marker.
Click chemistry catalytic reaction provided by the invention and fluorophor analytical approach are following:
The non-natural monose of 0.1 ~ 1.0 mmol/L is added to contains 0.5 mmol/L 4-ethinyl-N-ethyl-1,8-naphthalimide, 0.2 mmol/L Tris-triazoleamine, 1 mmol/L CuSO 4And in the PBS solution of 2 mmol/L sodium ascorbates, room temperature reaction 60 min.With 365 nm wavelength excitation reaction product, respectively organize fluorescence intensity with 465 nm emission wavelengths mensuration, draw the concentration dependent typical curve of azido group; Simultaneously, carry out the click chemistry reaction, confirm the Azide labeling effciency of antibody according to the fluorescence intensity of reaction product with the anti-her2 antibody surrogate non-natural monose of 3 μ mol/L metabolic markers.
 
Beneficial effect of the present invention: the present invention adopts the nitrine labelled antibody to carry out immunofluorescence analysis, and this invention can be used with other existing immunofluorescence techniques simultaneously, and the result does not disturb mutually.The present invention has set up a kind of new immunofluorescence antibody analysis method through a kind of novel antibody labeling technology of exploitation, has enriched immunofluorescence antibody test means, in the immune Research in future, possesses development potentiality and wide application prospect.
 
Description of drawings
Fig. 1 is the quantitative curve of nitrine;
Fig. 2 is the detection sensitivity of nitrine labelled antibody;
Fig. 3 is the cell dyeing analysis,
A: negative control; B: reaction group; C: positive control;
Fig. 4 is that the triple channel fluorescent dye is analyzed,
A: metabolic marker Her2 antibody staining; The EGFR4 dyeing of B:FITC labelled antibody; C: biotinylated GRP94 dyeing; D: triple channel multiple analysis.
 
Embodiment
Embodiment 1
The fluorescence labeling of Anti-HP15
1 mg NHS-FITC or NHS-rhodamine are dissolved among the 100 μ L DMSO, draw 4.7 μ L NHS-FITC subsequently or 3.5 μ L NHS-rhodamines dropwise add 1 mL Anti-HP15 antibody-solutions (0.1 mol/L, pH=9.0 Na 2CO 3-NaHCO 3, 1 mg/mL IgG) in, after stirring 1 h under the room temperature, centrifugal 10 min of 5000 r/min draw supernatant and in PBS (pH=7.2,0.02 mol/L Na 2HPO 4-NaH 2PO 4, 0.15 mol/L NaCl) in fully dialysis, remove unreacted NHS-FITC and NHS-rhodamine, the Anti-HP15 antibody of acquisition FITC or rhodamine mark is used for positive control.
 
Embodiment 2
Synthesizing of key compound (the non-natural monose that contains azido group)
The synthetic method of crucial compound is following: select to carry out Azide and acetylation, the non-natural monose that the acetylizad specificity of synthetic respectively preparation is modified like precursor monose such as N-acetylated mannan sugar, N-acetyl sialic acid, N-acetyl galactose and N-acetyl glucosamines through optimizing glycosyl protection strategy; To 4 bromo-1, add ethamine in the 8-naphthalimide, product is collected in the reaction back in ethanolic solution; Add TMS alkynes; In the tetrahydrofuran system,, obtain 4-ethinyl-N-ethyl-1, the 8-naphthalimide through tetrakis triphenylphosphine palladium and cuprous iodide catalytic reaction.
 
Embodiment 3
The metabolic marker of anti-her2 antibody
In the cell culture medium that the non-natural monose that embodiment 2 is synthesized slowly join, final concentration is 0.2 mM, join behind the mixing in the hybridoma, and 37 ℃, 5% CO 2Cultivate 72 h, the collecting cell suspension, centrifugal 3 min of 1000 r/min draw supernatant, with the antibody of antibody purification affinity column purifying metabolic marker.
 
Embodiment 4
The nitrine labelled amount of metabolic marker antibody is analyzed
With 1,3,4 of variable concentrations, 6-oxygen acetyl-2-'-deoxy-n-nitrine acetylglucosamine is added to and contains 0.5 mmol/L4-ethinyl-N-ethyl-1,8-naphthalimide, 0.2 mmol/L Tris-triazoleamine, 1 mmol/L CuSO 4And in the PBS solution of 2 mmol/L sodium ascorbates, behind room temperature 60 min, in 365 nm exciting lights measure down 465 nm down respectively organize fluorescence intensity, the drafting concentration dependent typical curve of azido group (Fig. 1); Simultaneously; With 3 μ mol/L metabolic marker antibody surrogates 1; 3,4,6-oxygen acetyl-2-'-deoxy-n-nitrine acetylglucosamine carries out the click chemistry reaction; Confirm to convert the Azide labeling effciency of antibody and learn that antibody labeling efficient is 3 azido groups of the about mark of each molecular antibody according to the fluorescence intensity of reaction product.
 
Embodiment 5
The sensitivity analysis of nitrine labelled antibody
Adopt enzyme linked immunosorbent assay analysis method to measure the sensitivity of metabolic marker detection of antibodies.100 μ L membranous antigens, the 5 μ g that in 96 hole ELISA Plates, add ultrasonication; 37 ° of C adopt 4 ° of C sealings of 1% BSA to spend the night after encapsulating 2 h; The antibody, the antibody of FITC mark and the antibody (10,1,0.1,0.01,0.001 and 0.001 μ g/mL) of rhodamine mark that add the identical metabolic marker of the concentration of 100 μ L serial dilutions subsequently, room temperature reaction 3 h.Fully after the washing, in nitrine labeled reactant group, add and contain 0.5 mmol/L 4-ethinyl-N-ethyl-1,8-naphthalimide, 0.2 mmol/L Tris-triazoleamine, 1 mmol/L CuSO 4And the PBS solution of 2 mmol/L sodium ascorbates, after the washing, measure the fluorescence intensity in every hole under the 365 nm exciting lights, emission wavelength is 465 nm; The antibody of the antibody of FITC mark and rhodamine mark excites and measures respectively the fluorescence intensity under 518 nm and 590 nm with respective excitation wavelength (488 nm and 570 nm).The EC of metabolic marker antibody 50Value is more lower slightly than control group; But at the same order of magnitude; Its detection limit is about 0.1 μ g; Be that the sensitivity of metabolic marker detection of antibodies is almost consistent with the detection sensitivity of existing commercial labelled reagent NHS-FITC and NHS-rhodamine, detectability is consistent, can be applied to (Fig. 2) in the immunofluorescence analysis as a kind of effective compensation process.
 
Embodiment 6
Immunofluorescence analysis
MCF-7 SK-BR-3 was cultivated 3 days in the RPMI that contains 10% FBS 1640 nutrient culture media, then with 1.25 * 10 5Cell transfer overnight incubation in the laser co-focusing culture plate; Subsequently with fixing 30 min of 4% paraformaldehyde room temperature; Fully after the washing sealing; Add 1 mg/mL metabolic marker antibody, add behind room temperature reaction 3 h and contain 0.5 mmol/L 4-ethinyl-N-ethyl-1,8-naphthalimide, 0.2 mmol/L Tris-triazoleamine, 1 mmol/L CuSO 4And the reaction of the PBS solution catalyzing of 2 mmol/L sodium ascorbates, observe under 365 nm through laser confocal microscope.Simultaneously, adopt the corresponding FITC mark two anti-cell fluorescences that carry out of identical unlabelled antibody and (embodiment 1 preparation) to dye, under 488 nm, analyze as positive control; Only add catalytic reaction solution and do not add an anti-cell and observe down in 365 nm as negative control group.When adopting the metabolic marker antibody staining to analyze, can observe blue-fluorescence (Fig. 3 B) under 365 nm significantly, and in not adding the negative control of antibody, almost not have fluorescence signal (Fig. 3 A); In positive control; Adopt the two anti-immuning fluorescent dyeing analysis that carry out of FITC mark; And fluorescence location and use nitrine labelled antibody coloration result consistent (Fig. 3 C); Be the method developed of the present invention no matter in detection sensitivity, still all suitable on the accuracy of testing result with existent method, can be widely used in the immunofluorescence check and analysis.
 
Embodiment 7
Complex staining is analyzed
MCF-7 SK-BR-3 is cultivated 3 d with the RPMI 1640 that contains 10% FBS, then, with 1.25 * 10 5Cell transfer is in the laser co-focusing double dish; Overnight incubation; The paraformaldehyde of adding 4% is fixed after the PBS washing, fully adds metabolic marker antibody, the anti-EGFR4 antibody of rabbit and biotinylated anti-GRP94 antibody simultaneously after the washing sealing, behind room temperature reaction 1 h; In double dish, add 0.5 mmol/L 4-ethinyl-N-ethyl-1,8-naphthalimide, 0.2 mmol/L Tris-triazoleamine, 1 mmol/L CuSO 4And the PBS solution of 2 mmol/L sodium ascorbates; Room temperature reaction 1 h; Fully after the washing, in double dish, add FITC mark goat anti-rabbit igg and strepadivin-CY3, behind room temperature 1 h; Fully washing is observed the fluorescence signal under 365 nm, 488 nm and the 550nm exciting light respectively with laser confocal microscope.When excitation wavelength is 365 nm, can observe tangible blue-fluorescence signal (Fig. 4 A) in the interior survey of cell membrane, i.e. 4-ethinyl-N-ethyl-1, the 8-naphthalimide produces autofluorescence after changing electron distributions; Under 488 nm exciting lights, can observe tangible FITC green fluorescence signal (Fig. 4 B) in the cell membrane outside; Under 550 nm exciting lights, can observe tangible Cy3 red fluorescence signal (Fig. 4 C).Fluorescence signal stack result such as Fig. 4 D show that 3 kinds of fluorescence signals can effectively merge, and signal do not disturb mutually, and promptly the fluorescence antibody analytical approach behind the metabolic marker can and be used with existing conventional method.
Embodiment 8
Synthetic and the chromogenic assay of fluorescent reagent
Respectively fluorophors such as Cy3, Cy5, FITC, TRITC, PE, DAPI, Texas red, RB200, Indo-1, quantum dot are carried out chemical modification, make it to contain alkynyl group.Carry out the click chemistry reaction according to embodiment 6 subsequently, make the azido group reaction on alkynyl and the antibody, form stable triazole ring, and then make sample to be detected possess lighting function, be convenient to detect.
 
Embodiment 9
Synthetic and the chromogenic assay of fluorescent reagent
To contain label groups such as His, GST, FLAG, HA, biotin respectively and carry out chemical modification, make it to contain alkynyl group.Carry out the click chemistry reaction according to embodiment 6 subsequently, make the azido group reaction on alkynyl and the antibody, form stable triazole ring, add the corresponding affinity ligand of various labels subsequently, and then make sample to be detected possess lighting function, be convenient to detect.

Claims (7)

1. the metabolic marker method of an antibody is characterized in that:
Metabolic marker thing when synthesizing as glycoprotein with the non-natural monose that contains azido group; Replace the normal monose in the NGP; Thereby make and be labeled protein and contain azido group; And then react through the click chemistry between azido group and the azide reaction group, make protein possess the label group that lighting function or coupling can be to be detected.
2. the metabolic marker method of antibody according to claim 1 is characterized in that the concrete steps of this method are following:
The non-natural monose that will contain azido group slowly joins in the cell culture medium, and final concentration is 0.2 mM, join behind the mixing in the hybridoma, and 37 ℃, 5% CO 2Cultivate 72 h, the collecting cell suspension, centrifugal 3 min of 1000 r/min draw supernatant, with the antibody of antibody purification affinity column purifying metabolic marker.
3. method according to claim 1 and 2 is characterized in that the described non-natural monose that contains azido group comprises 1,3,4; 6-oxygen acetyl-2-'-deoxy-n-nitrine acetylmannosamine, 1,3,4,6-oxygen acetyl-2-'-deoxy-n-nitrine acetyl sialic acid, 1; 3,4,6-oxygen acetyl-2-'-deoxy-n-nitrine acetylgalactosamine and 1; 3,4,6-oxygen acetyl-2-'-deoxy-n-nitrine acetylglucosamine.
4. method according to claim 1 and 2 is characterized in that described azide reaction group is to form the alkynyl compounds of triazole ring with azido group, and self possesses the coupling group of the characteristic of fluorescing or contain the label group.
5. method according to claim 4 is characterized in that the described coupling group that possesses the characteristic of fluorescing comprises Cy3, Cy5, FITC, TRITC, PE, DAPI, Texas red, RB200, Indo-1 and quantum dot.
6. method according to claim 4 is characterized in that described label group comprises His, GST, FLAG, HA and biotin.
7. the application of metabolic marker antibody in the fluoroscopic examination analytical approach of the said method preparation of claim 1.
CN201110148435A 2011-06-03 2011-06-03 Metabolic labeling method of antibody and application of antibody in fluorescence detection Pending CN102313801A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201110148435A CN102313801A (en) 2011-06-03 2011-06-03 Metabolic labeling method of antibody and application of antibody in fluorescence detection

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201110148435A CN102313801A (en) 2011-06-03 2011-06-03 Metabolic labeling method of antibody and application of antibody in fluorescence detection

Publications (1)

Publication Number Publication Date
CN102313801A true CN102313801A (en) 2012-01-11

Family

ID=45427146

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201110148435A Pending CN102313801A (en) 2011-06-03 2011-06-03 Metabolic labeling method of antibody and application of antibody in fluorescence detection

Country Status (1)

Country Link
CN (1) CN102313801A (en)

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103454268A (en) * 2013-04-19 2013-12-18 南京工业大学 Revertose quantitative detection method based on click reaction
CN103604791A (en) * 2013-11-29 2014-02-26 广西师范大学 Fluorescence spectroscopic method for measuring azides ions
CN103755778A (en) * 2014-02-24 2014-04-30 北京大学 Immunofluorescent labeling method for protein in living cell
CN104749369A (en) * 2013-12-31 2015-07-01 中国科学院深圳先进技术研究院 Fluorescent labeling method for living organisms having cell membrane structures
CN107810273A (en) * 2015-04-23 2018-03-16 西纳福克斯股份有限公司 With for or derived from β (1,4) N acetylgalactosamine transferases glycosyl transferase modified glucoprotein method
CN108169474A (en) * 2018-01-12 2018-06-15 中国科学院成都生物研究所 A kind of novel cell fixative
CN108728397A (en) * 2017-04-17 2018-11-02 中国科学院微生物研究所 The method that the foreign protein that insect protein or insect expression system are expressed is marked
CN108865918A (en) * 2017-05-09 2018-11-23 中国科学院微生物研究所 A method of the gram-positive bacterium of label survival and its cell wall
CN109897881A (en) * 2019-03-21 2019-06-18 中国科学院深圳先进技术研究院 The metabolism modification of non-togavirus labeling method orthogonal with biology in situ and application
CN112082976A (en) * 2019-06-14 2020-12-15 天津方得生物科技有限公司 In-vitro drug sensitivity detection method based on drug probe and tissue slice
CN113897412A (en) * 2021-09-23 2022-01-07 中国科学院城市环境研究所 Screening method of drug-resistant microorganisms by fluorescence method
US11634448B2 (en) 2016-06-15 2023-04-25 The General Hospital Corporation Metabolic labeling and molecular enhancement of biological materials using bioorthogonal reactions

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090264317A1 (en) * 2008-04-18 2009-10-22 University Of Massachusetts Functionalized nanostructure, methods of manufacture thereof and articles comprising the same
CN102012425A (en) * 2010-12-29 2011-04-13 南开大学 New immuno-fluorenscence labelling method

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090264317A1 (en) * 2008-04-18 2009-10-22 University Of Massachusetts Functionalized nanostructure, methods of manufacture thereof and articles comprising the same
CN102012425A (en) * 2010-12-29 2011-04-13 南开大学 New immuno-fluorenscence labelling method

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
DAVID J. VOCADLO等: "A chemical approach for identifying O-GlcNac-modified proteins in cells", 《PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICAN》, vol. 100, no. 16, 5 August 2003 (2003-08-05), XP 002987353, DOI: doi:10.1073/pnas.1632821100 *

Cited By (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103454268B (en) * 2013-04-19 2016-02-24 南京工业大学 A kind of reducing sugar quantitative detecting method based on click-reaction
CN103454268A (en) * 2013-04-19 2013-12-18 南京工业大学 Revertose quantitative detection method based on click reaction
CN103604791A (en) * 2013-11-29 2014-02-26 广西师范大学 Fluorescence spectroscopic method for measuring azides ions
CN103604791B (en) * 2013-11-29 2016-01-20 广西师范大学 A kind of fluorescence spectrum method measuring azides ion
CN104749369A (en) * 2013-12-31 2015-07-01 中国科学院深圳先进技术研究院 Fluorescent labeling method for living organisms having cell membrane structures
CN103755778A (en) * 2014-02-24 2014-04-30 北京大学 Immunofluorescent labeling method for protein in living cell
CN107810273B (en) * 2015-04-23 2022-09-27 西纳福克斯股份有限公司 Method for modifying glycoproteins with a glycosyltransferase that is or is derived from a beta- (1,4) -N-acetylgalactosamine transferase
CN107810273A (en) * 2015-04-23 2018-03-16 西纳福克斯股份有限公司 With for or derived from β (1,4) N acetylgalactosamine transferases glycosyl transferase modified glucoprotein method
US11634448B2 (en) 2016-06-15 2023-04-25 The General Hospital Corporation Metabolic labeling and molecular enhancement of biological materials using bioorthogonal reactions
CN108728397A (en) * 2017-04-17 2018-11-02 中国科学院微生物研究所 The method that the foreign protein that insect protein or insect expression system are expressed is marked
CN108728397B (en) * 2017-04-17 2022-05-20 中国科学院微生物研究所 Method for marking insect protein or foreign protein expressed by insect expression system
CN108865918B (en) * 2017-05-09 2022-01-07 中国科学院微生物研究所 Method for marking viable gram-positive bacteria and cell walls thereof
CN108865918A (en) * 2017-05-09 2018-11-23 中国科学院微生物研究所 A method of the gram-positive bacterium of label survival and its cell wall
CN108169474B (en) * 2018-01-12 2020-09-25 中国科学院成都生物研究所 Novel cell fixing agent
CN108169474A (en) * 2018-01-12 2018-06-15 中国科学院成都生物研究所 A kind of novel cell fixative
CN109897881A (en) * 2019-03-21 2019-06-18 中国科学院深圳先进技术研究院 The metabolism modification of non-togavirus labeling method orthogonal with biology in situ and application
CN112082976A (en) * 2019-06-14 2020-12-15 天津方得生物科技有限公司 In-vitro drug sensitivity detection method based on drug probe and tissue slice
CN113897412A (en) * 2021-09-23 2022-01-07 中国科学院城市环境研究所 Screening method of drug-resistant microorganisms by fluorescence method

Similar Documents

Publication Publication Date Title
CN102313801A (en) Metabolic labeling method of antibody and application of antibody in fluorescence detection
CN102012425A (en) New immuno-fluorenscence labelling method
Tagit et al. Fluorescence sensing of circulating diagnostic biomarkers using molecular probes and nanoparticles
Disney et al. The use of carbohydrate microarrays to study carbohydrate-cell interactions and to detect pathogens
CN102272600A (en) Method and device for immunoassay using nucleotide conjugates
WO2010059820A1 (en) Biosensor for detecting multiple epitopes on a target
JP2011527745A (en) Method for producing homogeneous plastic adherent aptamer magnetic fluorescent beads (Plastic-adherentaptamer-magneticbead-fluorphore) and other sandwich assays
CN101762706A (en) Method of detecting residue of small-molecule substance harmful to human body and a special kit
ITMI952049A1 (en) FLUORESCENT DYES OF THE SULFUR BENZ AND INDOCYANINE FAMILY
EP1813948A1 (en) Method of detecting target substances
Song et al. Carbohydrate arrays: recent developments in fabrication and detection methods with applications
CN108391432B (en) Bioconjugate molecules of heterocyclic compounds
US20190219600A1 (en) Devices, Compositions, and Methods for Measuring Molecules and Forces
Liet et al. Multifunctional glycoconjugates for recruiting natural antibodies against cancer cells
CN103597089A (en) New method for enzyme-mediated signal amplification
CN103698536A (en) Oncoprotein P185 detection kit
JPS59500735A (en) Methods and test kits for human cancer diagnosis
KR20170102344A (en) How to Detect Active Tuberculosis Markers
CN103649069B (en) Flash of light and aura 1,2-dioxetanes alkanes
Fu et al. Rapid and wash-free time-gated FRET histamine assays using antibodies and aptamers
CN104198740A (en) Nanometer biosensor for synchronously detecting glucose and cholesterol
US20210230676A1 (en) Sequential Staining for Multiplex Analyses of Tissues and Cells
CN103116025A (en) Kit for comprehensive detection of gastric cancer by means of time-resolved fluorescence method and application thereof
US20080241865A1 (en) Visible to near-infrared light probe comprising complex of cypridina luciferase and quantum dot
Kwon et al. Pd@ Pt nanoparticle-linked immunosorbent assay for quantification of Collagen type II

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20120111